Azenta, Inc. reported $614M of revenue over the trailing twelve months, +4.9% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $614M (to Q3 2026). Net income: −$123M, trailing twelve months to Q3 2026. Free cash flow: $9.9M, trailing twelve months to Q3 2026. Operating margin: −30%, trailing twelve months to Q3 2026.

AZTAAzenta, Inc.

Healthcare

$37.71+21% 1Y

$37.71

$16.0252 weeks$42.76

New on file: material impairmentOct 7, 2026what changed →

AZTA as reported

Azenta, Inc. reported $614M of revenue over the trailing twelve months, +4.9% on the year before. 11 reported series are charted on this page, each one as filed.

$614M

Revenue, trailing twelve months · to Q3 2026 · +4.9% against the twelve months before

Net income: −$123M
Net income · +8.5% year on year · trailing twelve months to Q3 2026
Free cash flow: $9.9M
Free cash flow · −81% year on year · trailing twelve months to Q3 2026
Operating margin: −30%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for AZTA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$614M	+4.9%	Q3 2026
Net income	−$123M	+8.5%	Q3 2026
EPS	−$2.67	+7.7%	Q3 2026
Gross margin	44%	n/a	Q3 2026
Operating margin	−30%	n/a	Q3 2026
Net margin	−22%	n/a	Q3 2026
ROE	−6.5%	n/a	Q3 2026
ROA	−5.3%	n/a	Q3 2026
ROIC	−1.7%	n/a	Q1 2022 · 18 quarters behind
Free cash flow	$9.9M	−81%	Q3 2026
P/E	63.4	n/a	Q1 2022 · 18 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.